Pyxis secured S$13 million in the first close of its S$18 million growth funding round, reflecting strong investor confidence in its vessel technology, commercial traction, and regional growth ...
Pyxis Oncology Inc. (NASDAQ: PYXS) on Thursday released preliminary data from its ongoing Phase 1 studies of micvotabart pelidotin (MICVO) for recurrent/metastatic head and neck squamous cell ...
Shares of Pyxis Oncology dropped after the pharmaceutical company said data from its trials on a treatment for a form of head and neck cancer showed a high incidence of adverse effects. The stock fell ...
Pyxis Oncology ( (PYXS)) has provided an announcement. On December 18, 2025, Pyxis Oncology reported positive preliminary Phase 1 data for its first-in-concept antibody-drug conjugate MICVO in ...
Investing.com -- Pyxis Oncology Inc (NASDAQ:PYXS) stock tumbled 49.9% in premarket trading Thursday after investors expressed disappointment with preliminary data from the company’s experimental ...
BOSTON - Pyxis Oncology, Inc. (NASDAQ:PYXS) announced preliminary data from ongoing Phase 1 clinical studies of its antibody-drug conjugate micvotabart pelidotin (MICVO) in patients with ...
46% confirmed objective response rate (ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR and 100% DCR observed with MICVO in ...
For James Westlake, a recent Naked Wines campaign required a camera able to produce excellent images in a fast, lightweight, handheld setup, and the PYXIS 12K fit the bill. James Westlake is a UK ...
Maroussi, Greece – November 21, 2025 – Pyxis Tankers Inc. (the “Company”) (NASDAQ Cap Mkts: PXS), (the “Company”, “we”, “our”, “us” or ...
Maroussi, Greece, November 19, 2025 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international shipping company with a focus on the seaborne transportation of refined petroleum products and dry ...
Most camper van conversions we cover here on autoevolution are based on brand-new vans. However, a slightly older chassis works just as well and can help save you a decent amount of money. Today, I'm ...
Fintel reports that on November 4, 2025, Guggenheim maintained coverage of Pyxis Oncology (NasdaqGS:PYXS) with a Buy recommendation. Analyst Price Forecast Suggests 60.63% Upside As of October 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results